Phase IIa Study on Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera

Abroad (travel likely)RecruitingPHASE2

Conditions

Polycythemia Vera (PV)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS), Tianjin, China
Contact: Study coordinator (Qirou Wang) · ec@ihcams.ac.cn · 022-23909095

Study leads

Lei Zhang, Doctor
Principal Investigator
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS)
Ting Niu, Doctor
Principal Investigator
West China Hospital
Wei Yang, Doctor
Principal Investigator
Shengjing Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)

Polycythemia Vera (PV)

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Los Angeles, United States

MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial

Polycythemia Vera (PV) · Essential Thrombocythemia (ET) · Myelofibrosis (MF)

Abroad (travel likely)RecruitingPHASE2

New York, United States

Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV

Polycythemia Vera

Abroad (travel likely)RecruitingPHASE2

Tianjin, China

Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)

Polycythemia Vera

Abroad (travel likely)Recruiting

Bergamo, Italy · Milan, Italy